Hyperkalemia resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 35: | Line 35: | ||
Shown below is an algorithm summarizing the approach to [[hyperkalemia]]. | Shown below is an algorithm summarizing the approach to [[hyperkalemia]]. | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | A00 | | | | | |A00=Potassium > 5.5 mEq/L}} | {{familytree | | | | | | | | | A00 | | | | | |A00='''Potassium > 5.5 mEq/L'''}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | A01 | | | | | |A01=R/O Pseudohyperkalemia<br>(Artifact, hemolysis, elevated WBC, elevated RBC, elevated platelets)<br><br>Repeat potassium level}} | {{familytree | | | | | | | | | A01 | | | | | |A01=R/O Pseudohyperkalemia<br>(Artifact, hemolysis, elevated WBC, elevated RBC, elevated platelets)<br><br>Repeat potassium level}} | ||
Line 43: | Line 43: | ||
{{familytree | | | | | | | | | B01 | | | | | |B01='''Assess [[EKG]]'''}} | {{familytree | | | | | | | | | B01 | | | | | |B01='''Assess [[EKG]]'''}} | ||
{{familytree | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| }} | {{familytree | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| }} | ||
{{familytree | | | C01 | | | | | | | | | | C02 | |C01=[[EKG]] changes | {{familytree | | | C01 | | | | | | | | | | C02 | |C01='''Presence of [[EKG]] changes'''<br>(Loss of P waves, hyperacute T waves and widened QRS)<br>[[Image:EKG_hyperkalemia.gif|center|250px]]|C02='''Absence of [[EKG]] changes'''<br><br> '''and''' <br><br>'''Stable patient'''}} | ||
{{familytree | | | |!| | | | | | | | | | | |!| |}} | {{familytree | | | |!| | | | | | | | | | | |!| |}} | ||
{{familytree | | | D01 | | | | | | | | | | |!|D01= '''1. Myocardial stabilization'''<br>IV [[calcium lactate gluconate|Ca gluconate]] 10% (contraindicated in digoxin toxicity and hypercalcemia)<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] and [[dextrose]] (glucose level monitoring is needed)<br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] by nebulizer (can cause tachycardia)<br><br>'''3. Lower total body potassium'''<br>Kayexalate<br>Loop diuretics (furosemide)<br>Hemodialysis if refractory}} | {{familytree | | | D01 | | | | | | | | | | |!|D01= '''1. Myocardial stabilization'''<br>IV [[calcium lactate gluconate|Ca gluconate]] 10% (contraindicated in digoxin toxicity and hypercalcemia)<br><br>'''2. Shift potassium from blood into cells'''<br>[[Insulin]] and [[dextrose]] (glucose level monitoring is needed)<br>[[Beta2-adrenergic receptor agonist|Beta2 agonists]] by nebulizer (can cause tachycardia)<br><br>'''3. Lower total body potassium'''<br>Kayexalate<br>Loop diuretics (furosemide)<br>Hemodialysis if refractory}} |
Revision as of 18:57, 27 July 2013
Hyperkalemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyperkalemia resident survival guide On the Web |
American Roentgen Ray Society Images of Hyperkalemia resident survival guide |
Risk calculators and risk factors for Hyperkalemia resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mahmoud Sakr, M.D. [2]
For hyperkalemia smart algorithm click here
Definition
Hyperkalemia is defined as a serum potassium concentration greater than 5.5 mEq/L in adults. Levels higher than 7 mEq/L can lead to significant hemodynamic compromise.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
- Acute renal failure
- Adrenal insufficiency
- Diabetic ketoacidosis
- Large IV doses of calcium chloride or calcium gluconate
- Massive hemolysis
- Metabolic acidosis
- Rapid tissue necrosis
- Rhabdomyolysis
- Tumor lysis syndrome
Common Causes
- Adrenal insufficiency
- Diabetic ketoacidosis
- Iatrogenic
- Medications: ACE inhibitors, angiotensin receptor blockers, amiloride, spironolactone, NSAIDS, ciclosporin, tacrolimus, trimethoprim, pentamidine, succinylcholine
- Pseudohyperkalemia
- Renal insufficiency
- Renal tubular acidosis type 4
Management
Shown below is an algorithm summarizing the approach to hyperkalemia.
Potassium > 5.5 mEq/L | |||||||||||||||||||||||||||||||||||||||||||||||||||
R/O Pseudohyperkalemia (Artifact, hemolysis, elevated WBC, elevated RBC, elevated platelets) Repeat potassium level | |||||||||||||||||||||||||||||||||||||||||||||||||||
Check vital signs ABC's Order an EKG Obtain a concise history and physical exam Order BUN, creatinine, glucose, ABG | |||||||||||||||||||||||||||||||||||||||||||||||||||
Assess EKG | |||||||||||||||||||||||||||||||||||||||||||||||||||
Presence of EKG changes (Loss of P waves, hyperacute T waves and widened QRS) | Absence of EKG changes and Stable patient | ||||||||||||||||||||||||||||||||||||||||||||||||||
1. Myocardial stabilization IV Ca gluconate 10% (contraindicated in digoxin toxicity and hypercalcemia) 2. Shift potassium from blood into cells Insulin and dextrose (glucose level monitoring is needed) Beta2 agonists by nebulizer (can cause tachycardia) 3. Lower total body potassium Kayexalate Loop diuretics (furosemide) Hemodialysis if refractory | |||||||||||||||||||||||||||||||||||||||||||||||||||
Potassium > 6 mEq/L | 5.5mEq/L<Potassium<6mEq/L | ||||||||||||||||||||||||||||||||||||||||||||||||||
1. Monitor for cardiac arrhythmia Place the patient on a closely monitored bed for potential arrhythmias 2. Shift potassium from blood into cells Insulin and dextrose Beta2 agonists by nebulizer 3. Lower total body potassium Kayexalate Loop diuretics (furosemide) Hemodialysis if refractory | Lower total body potassium Kayexalate Loop diuretics (furosemide) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stop any offending medications that are associated with hyperkalemia Stop oral or parenteral potassium Review potassium levels every 2-4 hours until stabilized Check levels of other electrolytes such as magnesium and phosphorus | |||||||||||||||||||||||||||||||||||||||||||||||||||